Biosimilar App Notes & Case Studies

  1. How Customer Forecasts Support The Integrity Of The Biopharma Supply Chain 6/30/2021

    Receiving customer forecasts as early and as completely as possible is critical to the success of the supply chain continuum.

  2. Platform Cell And Gene Therapy Media Development 9/9/2020

    This article highlights a case study on the removal of serum from the expansion step of an autologous cell therapy in a cost-effective manner without affecting cell performance.

  3. Empowering Control In Bioprocessing With Successful Automation Strategies 12/9/2021

    In a recent live event with Bioprocess Online, experts from within the industry at various stages of their automation journey discussed their approach to enhancing quality control and data integrity through automated technologies.

  4. Identifying New, Enhanced Device Delivery Solutions For Chronic Diseases 7/26/2021

    Needle innovations, including the usage of shorter needles with ultra-thin wall technology for prefilled syringes, support the delivery of drugs with greater volumes and viscosities, which greatly enhances end-user experience.

  5. The Insource Vs. Outsource Dilemma 2/21/2020

    Prior to making critical capacity decisions, a small biotech company completed an economic evaluation of manufacturing options to ensure it was selecting the best strategy for its manufacturing. Discover the critical elements of this analysis that may help to balance your assessment.

  6. A Model To Increase Yield In mAb Cell Culture Perfusion At Large Scale 9/28/2020

    As process intensification is adopted into large scale manufacturing, the responsibility of scale-down models to accurately represent the expanded operating space quickly follows. 

  7. The Importance Of CDMO Capacity For Viral Vectors: A Conversation With Forge’s Dr. Timothy Miller 10/4/2021

    In this episode of The Business of Biotech, Forge Biologics' Dr. Timothy Miller talks about the importance of increasing specialized CDMO capacity for cell and gene therapy applications.

  8. Transforming Your Biopharma Automation Capabilities 6/24/2021

    The seamless functionality of single-use technology equipped with a scalable distributed control system (DCS) empowers you to capture the benefits of collecting and sharing data while simultaneously creating a connected enterprise that grows with the pace of your business.

  9. Viral Vector Scale-Up: How Can We Bridge The Technology Gaps? 4/15/2021

    Unlocking the full potential of viral-vector based therapies requires an understanding of existing challenges in viral vector production and which technologies are now available in upstream and downstream processing to help address them.

  10. Optimizing Cell Culture Media: Increase Titer With Maintained Protein Quality 2/21/2020

    When evaluating media with the goal of increasing titers, it is important to ensure that protein quality is not negatively impacted. Here's how the process improvement can be performed reliably.